サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1429683

獣医用医薬品の世界市場レポート 2024

Veterinary Pharmaceuticals Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
獣医用医薬品の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

獣医用医薬品の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.3%の年間複合成長率（CAGR）で465億4,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、ペットの所有者の増加、人口の増加、可処分所得の増加、都市化、ペット保険の普及の拡大、市場を牽引する政府の支援などの要因に起因すると考えられます。予測期間中の主な動向としては、動物治療のための幹細胞療法への注目、抗生物質耐性に対処するための動物用医薬品へのナノテクノロジーの応用、チュアブル錠剤の開発、COVID-19の影響を緩和するための遠隔医療プラットフォームの利用、先進ワクチンの開発、スーパーコンボ寄生虫駆除剤への注目、サブユニットおよびウイルス粒子（VLP）ベースのワクチンの利用、戦略的パートナーシップおよび共同研究への集中などが挙げられます。

獣医用医薬品市場は、動物の病気の有病率の顕著な増加によって牽引されています。家畜と愛玩動物の両方で病気の発生率が急増しているため、効果的な治療のための医薬品が必要です。重要な例は、Banfield State of Pet Health Reportによると、犬の糖尿病症例が10,000頭当たり13.1症例から23.6症例へと79.7%増加したと報告されています。この病気の蔓延の増加は、獣医用医薬品に対する需要の高まりを強調しています。

ペットを飼う傾向の高まりにより、近い将来、獣医用医薬品市場の成長が促進されると予想されます。ペットの所有には、家畜の幸福に対する個人または世帯の法的および倫理的責任が伴います。ペットの飼い主の数が増加するにつれて、それに応じて、さまざまな種、品種、健康状態に対応する特殊な医薬品の需要も増加しています。米国ペット製品協会の報告書によると、2023年には米国の世帯の66%がペットを所有しており、2022年には62%であり、2022年には世帯の44.5%が犬、29%が猫を所有していることが明らかになりました。ペットの所有は、獣医用医薬品市場の主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の獣医用医薬品市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 獣医用ワクチン
  • 獣医用抗生物質
  • 獣医用寄生虫駆除剤
  • その他のタイプ
  • 世界の獣医用医薬品市場、動物タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コンパニオンアニマル
  • 家畜
  • 世界の獣医用医薬品市場、ワクチン別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 不活化ワクチン
  • 弱毒化ワクチン
  • 組換えワクチン
  • 世界の獣医用医薬品市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • その他の投与経路
  • 世界の獣医用医薬品市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 動物病院
  • 獣医クリニック
  • 薬局とドラッグストア

第7章 地域および国の分析

  • 世界の獣医用医薬品市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の獣医用医薬品市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 獣医用医薬品市場の競合情勢
  • 獣医用医薬品市場の企業プロファイル
    • Zoetis Inc
    • Merck &Co., Inc
    • Boehringer Ingelheim International Gmb
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale

第31章 その他の大手および革新的な企業

  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Kyoritsu Seiyaku Corporation
  • National Meditek
  • Fartovet Industry Limited
  • Hebei Chengshengtang Animal Pharmaceutical
  • Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd
  • Vvaan Lifesciences Private Limited
  • Century Pharmaceuticals Limited
  • Cargill India Pvt. Ltd.
  • Jurox Pty Ltd
  • Bayer
  • Veteq

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14654

Veterinary pharmaceuticals constitute a category of pharmacologically active drugs employed to control, prevent, and treat diseases in animals. These drugs exhibit their effects upon administration to animals and undergo rapid breakdown into active ingredients, primarily facilitated by small intestine metabolism.

The primary types of veterinary pharmaceuticals encompass veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other varieties. Veterinary vaccines offer protection against one or more diseases, mitigating their severity or preventing them altogether. The routes of administration include oral and various other routes tailored to different animal types, including companion animals and livestock. The vaccines themselves are classified into categories such as inactivated vaccines, attenuated vaccines, recombinant vaccines, and others, and they are supplied by diverse end-users, including veterinary hospitals, veterinary clinics, pharmacies, and drug stores.

The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $32.53 billion in 2023 to $35.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in the historical period can be attributed to factors such as the increased pet population, elevated overall spending by individuals on pets, the growing penetration of e-commerce platforms promoting online pharmacies, the growth of emerging markets, increasing government initiatives, and the heightened prevalence of diseases.

The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $46.54 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to factors such as the increasing ownership of pets, population growth, rising disposable income, urbanization, the growing penetration of pet insurance, and government support, which will drive the market. Major trends in the forecast period include a focus on stem cell therapy for treating animals, the application of nanotechnology in veterinary medicines to address antibiotic resistance, the development of chewable tablets, the use of telemedicine platforms to mitigate the impact of COVID-19, the development of advanced vaccines, a focus on super-combo parasiticides, the utilization of subunit and virus-such as particle (VLP)-based vaccines, and a concentration on strategic partnerships and collaborations.

The veterinary pharmaceuticals market is being driven by a notable increase in the prevalence rate of diseases among animals. The upsurge in disease incidence in both livestock and companion animals necessitates medicines for effective treatment. A significant example is the reported 79.7% increase in diabetes cases in dogs, from 13.1 cases per 10,000 to 23.6 cases, according to the Banfield State of Pet Health Report. This rise in disease prevalence underscores the heightened demand for veterinary pharmaceuticals.

The growing trend of pet ownership is anticipated to propel the growth of the veterinary pharmaceuticals market in the foreseeable future. Pet ownership involves the legal and ethical responsibility of individuals or households for the well-being of domesticated animals. As the number of pet owners increases, there is a corresponding rise in demand for specialized medications catering to various species, breeds, and health conditions. In 2023, a report from the American Pet Products Association Inc. revealed that 66% of US households owned pets, compared to 62% in 2022, with dogs being owned by 44.5% and cats by 29% of households in 2022. This surge in pet ownership is a key driver of the veterinary pharmaceuticals market.

Government agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regulate the veterinary pharmaceuticals market. Notably, the EU agencies require 6 to 12 months for the approval of veterinary medicinal products, and all parts of the registration dossier must be submitted together. In contrast, the US-FDA accepts phased submissions and assesses each technical section for 6 months. Efficient planning, effective communication, and careful consideration of regulatory policies are crucial for manufacturers in navigating the approval process and minimizing costs and timelines.

The emergence of generic drugs for animal care is a notable trend in the veterinary pharmaceuticals market. The cost-effectiveness of generic drugs has led to increased adoption by pet owners, with the FDA approving 22 generic animal drugs for cats and dogs. A survey of 520 veterinarians revealed that around 80% are using generic drugs to save pet owners money. Despite the lower profit margins compared to branded drugs, veterinarians are favoring generic drugs for their economic benefits.

Major companies in the veterinary pharmaceuticals market are innovating by introducing new products such as molidustat oral suspensions to expand customer bases and increase revenue. Elanco Animal Health Incorporated, for example, launched Varenzin-CA1 (molidustat oral suspension), the first medication for managing non-regenerative anemia in cats with chronic kidney disease (CKD). This needle-free oral suspension allows at-home administration, receiving provisional approval from the FDA. The unique features of Varenzin-CA1 showcase a commitment to providing novel therapies and expanding treatment options for animals with specific conditions or illnesses lacking effective treatments.

Major companies operating in the veterinary pharmaceuticals market report are Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, National Meditek, Fartovet Industry Limited, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd., Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd., Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, VitOMEK LCC, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Bond Vet, trifecta Pharmaceuticals USA LLC., Trifecta Pharmaceuticals USA LLC., Bio-Synthesis Inc., Small Door Veterinary, Fuzzy, Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd., Maure, Peru Animal Hospital, Miami County Veterinary Clinic, Cindy Fouts, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Physio Evolution, Herzliya Veterinary Hospital, Oron Veterinary Center, Dr Aviram Ezra - Veterinarian, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Aesthetics Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., M S J Afro Agro Pharmacy, Global Vet (U) Ltd

North America was the largest region in the veterinary pharmaceuticals market in 2023. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Other Veterinary Pharmaceuticals
  • 2) By Type Of Animal: Livestock; Companion Animals
  • 3) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines; Other Vaccines
  • 4) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
  • 5) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores
  • Companies Mentioned: Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Pharmaceuticals Market Characteristics

3. Veterinary Pharmaceuticals Market Trends And Strategies

4. Veterinary Pharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Veterinary Pharmaceuticals Market Size and Growth

  • 5.1. Global Veterinary Pharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Veterinary Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Veterinary Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Pharmaceuticals Market Segmentation

  • 6.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary Vaccines
  • Veterinary Antibiotics
  • Veterinary Parasiticides
  • Other Types
  • 6.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Companion Animals
  • Livestock Animals
  • 6.3. Global Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • 6.4. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Other Routes Of Administration
  • 6.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies And Drug Stores

7. Veterinary Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Pharmaceuticals Market

  • 8.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Pharmaceuticals Market

  • 9.1. China Veterinary Pharmaceuticals Market Overview
  • 9.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Pharmaceuticals Market

  • 10.1. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Pharmaceuticals Market

  • 11.1. Japan Veterinary Pharmaceuticals Market Overview
  • 11.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Pharmaceuticals Market

  • 12.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Pharmaceuticals Market

  • 13.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Pharmaceuticals Market

  • 14.1. South Korea Veterinary Pharmaceuticals Market Overview
  • 14.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Pharmaceuticals Market

  • 15.1. Western Europe Veterinary Pharmaceuticals Market Overview
  • 15.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Pharmaceuticals Market

  • 16.1. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Pharmaceuticals Market

  • 17.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Pharmaceuticals Market

  • 18.1. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Pharmaceuticals Market

  • 19.1. Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Pharmaceuticals Market

  • 20.1. Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Pharmaceuticals Market

  • 21.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
  • 21.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Pharmaceuticals Market

  • 22.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Pharmaceuticals Market

  • 23.1. North America Veterinary Pharmaceuticals Market Overview
  • 23.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Pharmaceuticals Market

  • 24.1. USA Veterinary Pharmaceuticals Market Overview
  • 24.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Pharmaceuticals Market

  • 25.1. Canada Veterinary Pharmaceuticals Market Overview
  • 25.2. Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Pharmaceuticals Market

  • 26.1. South America Veterinary Pharmaceuticals Market Overview
  • 26.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Pharmaceuticals Market

  • 27.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Pharmaceuticals Market

  • 28.1. Middle East Veterinary Pharmaceuticals Market Overview
  • 28.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Pharmaceuticals Market

  • 29.1. Africa Veterinary Pharmaceuticals Market Overview
  • 29.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Pharmaceuticals Market Competitive Landscape
  • 30.2. Veterinary Pharmaceuticals Market Company Profiles
    • 30.2.1. Zoetis Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co., Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boehringer Ingelheim International Gmb
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Elanco Animal Health Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ceva Sante Animale
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Veterinary Pharmaceuticals Market Other Major And Innovative Companies

  • 31.1. Virbac SA
  • 31.2. Dechra Pharmaceuticals PLC
  • 31.3. Vetoquinol S.A.
  • 31.4. Phibro Animal Health Corporation
  • 31.5. Kyoritsu Seiyaku Corporation
  • 31.6. National Meditek
  • 31.7. Fartovet Industry Limited
  • 31.8. Hebei Chengshengtang Animal Pharmaceutical
  • 31.9. Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd
  • 31.10. Vvaan Lifesciences Private Limited
  • 31.11. Century Pharmaceuticals Limited
  • 31.12. Cargill India Pvt. Ltd.
  • 31.13. Jurox Pty Ltd
  • 31.14. Bayer
  • 31.15. Veteq

32. Global Veterinary Pharmaceuticals Market Competitive Benchmarking

33. Global Veterinary Pharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

35. Veterinary Pharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Veterinary Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Pharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer